UConn researchers are at the forefront of new discoveries and understanding about the smallest molecules in the body that can have a momentous impact on human health.
Mar 26, 2013
0
0
Researchers at Moffitt Cancer Center and colleagues have investigated the safety, efficacy and the maximum tolerated dose of pomalidomide for patients with multiple myeloma who have disease relapsed after treatments with ...
Jan 24, 2013
0
0
In a landmark study, an international consortium led by researchers at Children's Hospital of Philadelphia (CHOP) published the final results of a key clinical trial of the gene therapy CASGEVY (exagamglogene autotemcel) ...
Apr 25, 2024
0
71
Researchers have released the first open-source data sets from the non-human primate brain imaging consortium.
Oct 4, 2018
0
0
Social environment is a key factor in the risk of developing prostate cancer. Ph.D. student Charlotte Salmon and Professor Marie-Élise Parent of Institut national de la recherche scientifique (INRS) have shown that widowers ...
Aug 12, 2021
0
7
Newly published research from an international consortium led by the University of Minnesota's Masonic Cancer Center has the potential to transform the landscape of ovarian cancer treatment.
Feb 27, 2024
0
37
A research consortium made up of the Virgen del Rocio hospital in Seville, Sant Joan de Deu and the Bellvitge Biomedical Research Institute (IDIBELL) in Barcelona, has found a new therapeutic alternative for children who ...
Jul 7, 2015
0
19
(Medical Xpress)—The holidays can be a stressful time for parents of the six million children in the United States with food allergies. With so many parties and gifts involving food, parents may worry that their children ...
Dec 27, 2012
0
0
Peanut allergy prevention achieved from early peanut consumption in at-risk infants persists after a one-year period of avoiding peanut, a clinical trial has found. The LEAP-ON clinical trial (Persistence of Oral Tolerance ...
Mar 4, 2016
0
1
The idea that the immune system 'monitors and prevents' the development of cancer, which is called 'cancer immune vigilance," was initially proposed at the beginning of the last century. Since then, epidemiological studies ...
Jun 25, 2020
0
1
